Terminated NA INTERVENTIONAL NCT00003654

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Diagnostic Study of Patent Blue V Dye to Identify Sentinel Lymph Nodes in Patients With Stage I or IIA Breast Cancer

Sponsor: UNICANCER

Interventions lymphangiography patent blue V dye radionuclide imaging sentinel lymph node biopsy technetium Tc 99m sulfur colloid

Updated 6 times since 2017 Last updated: Feb 19, 2021 Started: Sep 30, 1997 Primary completion: Jan 31, 2000 Completion: Jan 31, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from UNICANCER

See all terminations from UNICANCER

Other Breast Cancer trials with similar outcome

Browse all Breast Cancer trials

This NA trial investigates Breast Cancer and is currently terminated or withdrawn. UNICANCER leads this study, which shows 6 recorded versions since 1997 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Mar 2021 — Jul 2024 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Jan 2021 — Mar 2021 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Sep 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

UNICANCER

Data source: UNICANCER

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Strasbourg, France